Differentiating effective data mining from fishing, trapping, and cruelty to numbers

Journal of Managed Care Pharmacy

Volumn 13, Issue 6, 2007, Pages 517-527

  Fairman, Kathleen A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; CITALOPRAM; FLUOXETINE; FLUVOXAMINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMIPRAMINE; INSULIN; INSULIN LISPRO; MOCLOBEMIDE; NEFAZODONE; PAROXETINE; SERTRALINE; STOMACH SECRETION INHIBITOR; VENLAFAXINE;

ACADEMIC ACHIEVEMENT; COST BENEFIT ANALYSIS; COST OF ILLNESS; DATA ANALYSIS; DATA MINING; DECISION SUPPORT SYSTEM; DEPRESSION; DIABETES MELLITUS; EDITORIAL; GOOD CLINICAL PRACTICE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH STATISTICS; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HELICOBACTER INFECTION; HUMAN; INFORMATION PROCESSING; MANAGED CARE; MEDICAL DECISION MAKING; MEDICAL INFORMATION SYSTEM; OUTCOME ASSESSMENT; PATIENT CARE; PHARMACY; PRACTICE GUIDELINE; PRESCRIPTION; RESEARCH ETHICS; RETROSPECTIVE STUDY; SENSITIVITY ANALYSIS; SYSTEMATIC ERROR; COST; EPIDEMIOLOGY; INSURANCE; METHODOLOGY; ORGANIZATION AND MANAGEMENT; REPRODUCIBILITY; STATISTICS;

BIAS (EPIDEMIOLOGY); COSTS AND COST ANALYSIS; HUMANS; INSURANCE CLAIM REVIEW; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; RETROSPECTIVE STUDIES;

EID: 34548572168     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2007.13.6.517     Document Type: Editorial

References (42)

1. Quotations about statistics. Available at: wwwquotegarden.com/ statistics.html. Accessed May 29, 2007.
2. The theory of probability: Ion Saliu's Paradox. Available at: http://about-probability.org/ion.htm. Accessed June 2, 2007.
3. Kahlenberg R. Learning from James Coleman. Public Interest. June 22, 2001 Available at: http://findarticles.com/p/articles/mi_m0377/ is_2001_Summer/ai_76812255. Accessed June 2, 2007.
4. Pedhazur E. Multiple Regression in Behavioral Research: Explanation and Prediction. New York, NY: CBS College Publishing; 1982:137.
5. McCombs JS, Nichol MB, Newman CM, Sclar DA. The costs of interrupting antihypertensive drug therapy in a Medicaid population. Med Care. 1994;32(3): 214-26.
6. Sewitch MJ, Blais R, Rahme E, Bexton B, Galarneau S. Receiving guideline-concordant pharmacotherapy for major depression: impact on ambulatory and inpatient health service use. Can J Psychiat. 2007;52(3):191-200.
7. Wu EQ, Birnbaum HG, Mareva M, et al. Economic burden and comorbidities of atrial fibrillation in a privately insured population. Curr Med Res Opin. 2005; 21(10):1693-99.
8. Carroll J. Predictive modeling expands its book of techniques. Manag Care. November 2005. Available at: http://www.managedcaremag.com/ archives/0511/0511. predictive.html. Accessed June 29, 2007.
9. Boa M. Predictive modeling raises opportunities and issues for actuaries and insurers, CAS annual meeting is told. Casualty Actuarial Soc. December 19, 2005. Available at: http://www.casact.org/media/press/ index.cfm?fa=121905b. Accessed June 29, 2007.
10. Axelrod RC, Vogel D. Predictive modeling in health plans. Dis Manage Health Outcomes. 2003; 11(12):779-87.
11. Benko LB. Long-range forecast: partly healthy, chance of storms. Mod Healthc. May 3, 2004. Available at: http://www.activehealthmanagement.com/news/articles/ predictivemodeling.pdf. Accessed June 29, 2007.
12. Carlson B. Predictive modeling, sharp lens on near future. Manag Care Mag. July 2003. Available at: http://www.managedcaremag.com/archives/ 0307/0307.predictive. html. Accessed October 3, 2006.
13. Stadel BV, Colman E, Sahlroot T. Misleading use of risk ratios. Lancet. 2005;365 (9467):1306-07.
14. Gann PH, Morrow M. Combined hormone replacement therapy and breast cancer: a single-edged sword. JAMA. 2003;289(24):3303-06.
15. Goodman AC. Beware "Texas sharp shooter" in rate ratios of progression. BMJ. 2007;334:440.
16. Krueger KP, Armstrong EP Langley PC. The accuracy of asthma and respiratory disease diagnostic codes in a managed medical claims database. Dis Manage. 2001;4(4):155-61.
17. Linder JA, Bates DW, Williams DH, Connolly MA, Middleton B. Acute infections in primary care: accuracy of electronic diagnoses and electronic antibiotic prescribing. J Am Med Inform Assoc. 2006;13(1):61-66.
18. Kiyota Y, Schneeweiss S, Glynn RJ, Cannuscio CC, Avorn J, Solomon DH. Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records. Am Heart J. 2004;148(1):99-104.
19. Lorence DP, Spink A. Regional variation in medical systems data: influences on upcoding. J Med Syst. 2002;26(5):369-81.
20. Rost K, Smith R, Matthews DB, Guise B. The deliberate misdiagnosis of major depression in primary care. Arch Fam Med. 1994;3(4):333-37.
21. LaFleur J. Evaluating the relationship between diabetes treatment and health care costs - measuring the atom with a yardstick? J Manag Care Pharm. 2005;11(7):588-89. Available at: http://www.amcp.org/data/ jmcp/Editolials_584-5892.pdf. Accessed June 29, 2007.
22. Peabody JW, Luck J, Jain S, Bertenthal D, Glassman P. Assessing the accuracy of administrative data in health information systems. Med Care. 2004;42(11):1066-72.
23. Sherry S, Secnik K, Oglesby AK. Relationship of glycemic control to total diabetes-related costs for managed care health plan members with type 2 diabetes. J Manag Care Pharm. 2005; 11(7):559-64. Available at: http://www.amcp.org/data/jmcp/Original%20Research_559_564.pdf. Accessed June 29, 2007.
24. Russo R. Apples and oranges. For Rec. 2007;19(1):26. Available at: www.fortherecordmag.com/archives/ftr_01082007p26.shtml. Accessed June 2, 2007.
25. Empire Medicare Services local coverage determination coding guideline. Posted February 16, 2006. Available from author on request.
26. Himmelfarb J. Chronic kidney disease and the public health: gaps in evidence from interventional trials. JAMA. 2007;297(23):2630-32.
27. Nissenson AR, Wade S, Goodnough T, Knight K, Dubois RW. Economic burden of anemia in an insured population. J Manag Care Pharm. 2005;11(7):565-74. Available at: http://www.amcp.org/data/jmcp/ Original%20Research_565_574.pdf. Accessed June 18, 2007.
28. McMullin ST, Lonergan TP, Rynearson CS. Twelve-month drug cost savings related to use of an electronic prescribing system with integrated decision support in primary care. J Manag Care Pharm. 2005;11(4):322-32. Available at: http://www.amcp.org/daLa/jmcp/ contemporary_322_332.pdf. Accessed June 18, 2007.
29. Briesacher BA, Stuart B, Xiaoqang R, Doshi JA, Wrobel MV. Medicare beneficiaries and the impact of gaining prescription drug coverage on inpatient and physician spending. Health Serv Res. 2005;40(5):1279-96.
30. Agency for Health Research and Quality. Comparative effectiveness of angiotensin-converting enzyme, inhibitors (ACEIs) and angiotensin II receptor antagonists (ARBs) for treating hypertension. Available at: http://effectivehealthcare.ahrq.gov/repFiles/ ACEIs_v_ARBs_Draft_Report.pdf. Accessed June 13, 2007.
31. Fairman KA, Motheral BR. Helicobacter pylori eradication in clinical practice: retreatment rates and costs of competing regimens. Ann Pharmacother. 2000;34(6):721-28.
32. Karp I, Chen SF, Note L. Sex differences in the effectiveness of statins after myocardial infarction. CMAJ. 2007;176(3):333-38.
33. Fintel D, Joyce A, Mackell J, Graff J, Kuntze E, Ollendorf DA. Reduced mortality rates after intensive statin therapy in managed-care patients. Value Health. 2007;10(2):161-69.
34. Chen K, Chang EY, Summers KH, Obenchain RL, Yu-Isenberg KS, Sun P. Comparison of costs and utilization between users of insulin lispro versus users of regular insulin in a managed care setting. J Manag Care Pharm. 2005;11(5):376-82. Available at: http://www.amcp.org/ data/jmcp/research_376-382.pdf. Accessed June 29, 2007.
35. Bullano MF, Fisher MD, Grochulski WD, Menditto L, Willey VJ. Hypoglycemic events and glycosylated hemoglobin values in patients with type 2 diabetes mellitus newly initiated on insulin glargine or premixed insulin combination products. Am J Health Syst Pharm. 2006;63(24):2473-82.
36. Insinga RF, Itzler RF, Pellissier JM. Acute/subacute Herpes Zoster: health care resource utilisation and costs in a group of US health plans. Pharmacoeconomics. 2007;25(2):155-69.
37. Lagakos SW. The challenge of subgroup analyses - reporting without distorting. N Engl J Med. 2006;355(5):533.
38. Mason JM, Mason AR. The generalisability of pharmacoeconomic studies: issue and challenges ahead. Pharmacoeconomics. 2006;24(10):937-45.
39. Norusis MJ. Descriptive statistics. In: SPSS for Windows Base System User's Guide Release 6.0. Chicago, IL SPSS, Inc.; 1993:167-80.
40. O'Connell RL, Gebski VJ, Keech AC. Making sense of trial results: outcomes and estimation. Med J Aust. 2004;180(3):128-30. Available at: http://www.mja.com.au/public/issues/180_03_20204/oco10835_fm.html. Accessed June 2, 2007.
41. JMCP author guidelines. Available at: www.amcp.org/cfr/waSys/ f.cfc?method=getLinkAsset&rid=1A2CFB98. Accessed June 2, 2007.
42. Howden CW, Blume SW, Lissovoy G. Practice patterns for managing Helicobacter pylori infection and upper gastrointestinal symptoms. Am J Manag Care. 2007;13(1):37-44.